PH15596A - Antibiotic crystalline epimer - Google Patents

Antibiotic crystalline epimer

Info

Publication number
PH15596A
PH15596A PH23927A PH23927A PH15596A PH 15596 A PH15596 A PH 15596A PH 23927 A PH23927 A PH 23927A PH 23927 A PH23927 A PH 23927A PH 15596 A PH15596 A PH 15596A
Authority
PH
Philippines
Prior art keywords
epimer
antibiotic
crystalline
antibiotic crystalline
crystalline epimer
Prior art date
Application number
PH23927A
Other languages
English (en)
Inventor
Shang Yang Kuo
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH15596A publication Critical patent/PH15596A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH23927A 1979-05-01 1980-04-21 Antibiotic crystalline epimer PH15596A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/035,037 US4252953A (en) 1979-05-01 1979-05-01 Antibiotic crystalline epimer

Publications (1)

Publication Number Publication Date
PH15596A true PH15596A (en) 1983-02-28

Family

ID=21880235

Family Applications (1)

Application Number Title Priority Date Filing Date
PH23927A PH15596A (en) 1979-05-01 1980-04-21 Antibiotic crystalline epimer

Country Status (34)

Country Link
US (1) US4252953A (fr)
EP (1) EP0018811B1 (fr)
JP (1) JPS55153788A (fr)
KR (1) KR840000078B1 (fr)
AR (1) AR230450A1 (fr)
AT (1) AT370108B (fr)
AU (1) AU538283B2 (fr)
BE (1) BE882980A (fr)
BG (1) BG34905A3 (fr)
CA (1) CA1138867A (fr)
CH (1) CH646434A5 (fr)
CS (1) CS226013B2 (fr)
DD (1) DD150352A5 (fr)
DE (1) DE3061751D1 (fr)
DK (1) DK177980A (fr)
EG (1) EG14719A (fr)
ES (1) ES8105316A1 (fr)
FI (1) FI801345A (fr)
FR (1) FR2455605A1 (fr)
GB (1) GB2047707B (fr)
GR (1) GR68202B (fr)
HU (1) HU184750B (fr)
IE (1) IE49775B1 (fr)
IL (1) IL59912A (fr)
IT (1) IT1141935B (fr)
LU (1) LU82411A1 (fr)
MY (1) MY8500601A (fr)
NZ (1) NZ193528A (fr)
PH (1) PH15596A (fr)
PL (1) PL125579B1 (fr)
PT (1) PT71140A (fr)
RO (1) RO79684A (fr)
SU (1) SU860705A3 (fr)
ZA (1) ZA802475B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
DE102004049396A1 (de) * 2003-10-08 2005-07-28 Behr Gmbh & Co. Kg Bauteil, insbesondere Hybridträger für ein Fahrzeug, und Verfahren zur Herstellung eines derartigen Bauteils sowie Verwendung eines derartigen Bauteils
WO2005035338A1 (fr) * 2003-10-08 2005-04-21 Behr Gmbh & Co. Kg Procede et dispositif pour fabriquer un composant, en particulier un composant hybride de poutre transversale de vehicule, un tel composant et utilisation de celui-ci

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1158A (en) * 1976-03-25 1983-01-28 Shionogi & Co Arylmalonamido-1-oxadethiacephalosporins
CA1085392A (fr) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporines
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US4124762A (en) * 1977-11-07 1978-11-07 Yeda Research And Development Co., Ltd. 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
US4125715A (en) * 1977-11-25 1978-11-14 Yeda Research And Development Co. Ltd. 7-[(Substituted-isothioureamethyl)phenyl]-acetamidocephalosporin derivatives

Also Published As

Publication number Publication date
JPS55153788A (en) 1980-11-29
CH646434A5 (fr) 1984-11-30
AU5791480A (en) 1980-11-06
GB2047707A (en) 1980-12-03
AR230450A1 (es) 1984-04-30
EP0018811B1 (fr) 1983-01-26
RO79684A (fr) 1982-08-17
AU538283B2 (en) 1984-08-09
GB2047707B (en) 1983-05-18
IE49775B1 (en) 1985-12-11
AT370108B (de) 1983-03-10
MY8500601A (en) 1985-12-31
DE3061751D1 (en) 1983-03-03
KR830002779A (ko) 1983-05-30
EG14719A (en) 1985-06-30
US4252953A (en) 1981-02-24
EP0018811A1 (fr) 1980-11-12
PL125579B1 (en) 1983-05-31
DD150352A5 (de) 1981-08-26
DK177980A (da) 1980-11-02
ES491085A0 (es) 1981-05-16
BG34905A3 (en) 1983-12-15
KR840000078B1 (ko) 1984-02-08
LU82411A1 (fr) 1980-07-31
GR68202B (fr) 1981-11-10
PL223753A1 (fr) 1981-02-13
NZ193528A (en) 1982-03-23
IE800882L (en) 1980-11-01
FI801345A (fi) 1980-11-02
IT8021697A0 (it) 1980-04-29
IT1141935B (it) 1986-10-08
PT71140A (en) 1980-05-01
HU184750B (en) 1984-10-29
JPH0118077B2 (fr) 1989-04-03
FR2455605A1 (fr) 1980-11-28
ZA802475B (en) 1981-12-30
ATA220980A (de) 1982-07-15
ES8105316A1 (es) 1981-05-16
CA1138867A (fr) 1983-01-04
FR2455605B1 (fr) 1983-05-27
IL59912A (en) 1984-02-29
BE882980A (fr) 1980-10-27
SU860705A3 (ru) 1981-08-30
CS226013B2 (en) 1984-03-19

Similar Documents

Publication Publication Date Title
GB2063871B (en) Cephalosporin antibiotic
JPS5657797A (en) Antibiotic uu59761
GB2064513B (en) Cephalosporin antibiotic
JPS5490194A (en) Novel cephalosporin antibiotic
IL60216A0 (en) Antibiotic a-30912 factor h
IL49100A0 (en) Antibiotic crystalline form
AU528686B2 (en) Antibiotic pa-31088-iv
DE3068977D1 (en) Antibiotic compositions
ZA802475B (en) Antibiotic crystalline epimer
JPS5422360A (en) Antibiotic compound
GB2056985B (en) Antibiotic em4940
ZA804150B (en) Antibiotic compounds
GB2061946B (en) Macrolide antibiotic
GB2003465B (en) Antibiotic compounds
JPS55167290A (en) Cephalosporin antibiotic
ZA808001B (en) Antibiotic compositions
JPS55143992A (en) Crystallization
JPS55115888A (en) Cephalosporin antibiotic
JPS55104288A (en) Crystalline 33hydroxycephalosporin solvate
GB2001052B (en) Antibiotic compound
ZA803333B (en) Antibiotic a-30912 factor h
GB2042501B (en) Antibiotic ax-127b-1
GB2059946B (en) Antibiotic ncs-c
JPS5657790A (en) Cephalosporin antibiotic
IE790743L (en) Antibacterial antibiotic bm782